Biotech · Private company
PharmaJet, Inc.
Track this companyFree. Adds PharmaJet, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- COMIRNATY®Phase 2 · Evaluate Immune Responses Following mRNA COVID-19 Vaccine Administration Through Different Delivery Routes in Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- PharmaJet Stratis Needle-free Injection SystemPhase 1 · Vaccine ReactionClinicalTrials.gov · fetched Nov 12, 2026
- PharmaJet Tropis Needle-free Injection SystemPhase 1 · Vaccine ReactionClinicalTrials.gov · fetched Nov 12, 2026
- Venezuelan Equine Encephalitis DNA VaccinePhase 1 · Vaccine ReactionClinicalTrials.gov · fetched Nov 12, 2026
- 2011-2012 Fluzone trivalent inactivated influenza vaccineInfluenza ProphylaxisClinicalTrials.gov · fetched Nov 12, 2026
- Needle and SyringeInfluenza ProphylaxisClinicalTrials.gov · fetched Nov 12, 2026
- Stratis Jet InjectorInfluenza ProphylaxisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- mRNA Covid-19 Vaccine Immune Response Comparisons Using Different Delivery RoutesPHASE2 · NOT_YET_RECRUITING · started May 1, 2025ClinicalTrials.gov NCT06919796 · fetched Nov 12, 2026
- Safety, Reactogenicity and Immunogenicity of a Venezuelan Equine Encephalitis DNA Vaccine Candidate Administered by Jet InjectionPHASE1 · UNKNOWN · started Oct 16, 2023ClinicalTrials.gov NCT06002503 · fetched Nov 12, 2026
- Phase 1/2 Study of Combination Immunotherapy and Messenger Ribonucleic Acid (mRNA) Vaccine in Subjects With NSCLCPHASE1_PHASE2 · COMPLETED · started Dec 20, 2017ClinicalTrials.gov NCT03164772 · fetched Nov 12, 2026
- Clinical Trial Assessing the Immunologic Response to a Influenza Vaccine Delivered Using an Jet Injection Device or a Needle SyringePHASE4 · COMPLETED · started Jan 1, 2012ClinicalTrials.gov NCT01644149 · fetched Nov 12, 2026